CollPlant Biotechnologies (CLGN) Cost of Revenue (2017 - 2025)
Historic Cost of Revenue for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to $269000.0.
- CollPlant Biotechnologies' Cost of Revenue fell 110.29% to $269000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $915000.0, marking a year-over-year decrease of 5696.14%. This contributed to the annual value of $1.6 million for FY2024, which is 1838.27% down from last year.
- CollPlant Biotechnologies' Cost of Revenue amounted to $269000.0 in Q3 2025, which was down 110.29% from $186000.0 recorded in Q2 2025.
- In the past 5 years, CollPlant Biotechnologies' Cost of Revenue registered a high of $886000.0 during Q1 2021, and its lowest value of $31000.0 during Q1 2022.
- Its 5-year average for Cost of Revenue is $350736.8, with a median of $272000.0 in 2024.
- Its Cost of Revenue has fluctuated over the past 5 years, first soared by 975426.79% in 2021, then plummeted by 9650.11% in 2022.
- CollPlant Biotechnologies' Cost of Revenue (Quarter) stood at $548000.0 in 2021, then plummeted by 88.69% to $62000.0 in 2022, then surged by 1146.77% to $773000.0 in 2023, then plummeted by 64.81% to $272000.0 in 2024, then dropped by 1.1% to $269000.0 in 2025.
- Its Cost of Revenue stands at $269000.0 for Q3 2025, versus $186000.0 for Q2 2025 and $188000.0 for Q1 2025.